- Title
- Ovarian cancer, cancer stem cells and current treatment strategies : a potential role of magmas in the current treatment methods
- Creator
- Ahmed, Nuzhat; Kadife, Elif; Raza, Ali; Short, Mary; Jubinsky, Paul; Kannourakis, George
- Date
- 2020
- Type
- Text; Journal article; Review
- Identifier
- http://researchonline.federation.edu.au/vital/access/HandleResolver/1959.17/172389
- Identifier
- vital:14469
- Identifier
-
https://doi.org/10.3390/cells9030719
- Identifier
- ISBN:2073-4409
- Abstract
- Epithelial ovarian cancer (EOC) constitutes 90% of ovarian cancers (OC) and is the eighth most common cause of cancer-related death in women. The cancer histologically and genetically is very complex having a high degree of tumour heterogeneity. The pathogenic variability in OC causes significant impediments in effectively treating patients, resulting in a dismal prognosis. Disease progression is predominantly influenced by the peritoneal tumour microenvironment rather than properties of the tumor and is the major contributor to prognosis. Standard treatment of OC patients consists of debulking surgery, followed by chemotherapy, which in most cases end in recurrent chemoresistant disease. This review discusses the different origins of high-grade serous ovarian cancer (HGSOC), the major sub-type of EOC. Tumour heterogeneity, genetic/epigenetic changes, and cancer stem cells (CSC) in facilitating HGSOC progression and their contribution in the circumvention of therapy treatments are included. Several new treatment strategies are discussed including our preliminary proof of concept study describing the role of mitochondria-associated granulocyte macrophage colony-stimulating factor signaling protein (Magmas) in HGSOC and its unique potential role in chemotherapy-resistant disease.
- Relation
- Cells Vol. 9, no. 3 (Mar 2020), p. 35
- Rights
- http://creativecommons.org/licenses/by/4.0/
- Rights
- Copyright © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license
- Rights
- Open Access
- Rights
- This metadata is freely available under a CCO license
- Subject
- 1103 Clinical Sciences; Ovarian cancer; Treatment; Magmas; Epithelial-mesenchymal transition; Olaparib maintenance therapy; Platinum-resistant ovarian; Patient-derived organoids; Folate; Receptor-alpha; Fallopian-tube; Surface epithelium; Breast-cancer; Aldehyde dehydrogenase; Initiating cells
- Full Text
- Reviewed
- Hits: 3709
- Visitors: 3820
- Downloads: 174
| Thumbnail | File | Description | Size | Format | |||
|---|---|---|---|---|---|---|---|
| View Details Download | SOURCE1 | Published | 3 MB | Adobe Acrobat PDF | View Details Download |